Related Experiment Video

Updated: Jun 26, 2026

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update

Stephanie J Lee1, Kirsten M Williams2, Stefanie Sarantopoulos3

  • 1Clinical Research Division and Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.

Transplantation and Cellular Therapy
|May 23, 2025
PubMed

Insights

Progress on chronic graft-versus-host disease (GVHD) research is modest. A 2020 NIH project set goals for GVHD clinical trials, with an interim review in 2024 showing some studies are advancing the field.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • The 2020 NIH Consensus Development Project aimed to address knowledge gaps in chronic graft-versus-host disease (GVHD).
  • Chronic GVHD remains a significant challenge post-hematopoietic stem cell transplantation.
  • Actionable recommendations were established to advance the understanding, prevention, and treatment of chronic GVHD.

Purpose of the Study:

  • To review progress made on the 2020 recommendations for chronic GVHD clinical trials.
  • To assess the current trajectory of the field towards achieving established goals.
  • To redefine the research agenda for future chronic GVHD studies.

Main Methods:

  • Convening working groups to review prior recommendations.
  • Evaluating progress against established goals for chronic GVHD research.
  • Assessing the impact of new data and identifying areas needing further investigation.

Main Results:

  • Modest progress has been observed across most research initiatives.
  • Several ongoing studies are directly addressing key recommendations from the 2020 project.
  • The working groups' reports provide a summary of advancements and future directions.

Conclusions:

  • The field is making slow but steady progress in chronic GVHD research.
  • Future research should focus on key recommendations to accelerate advancements.
  • Anticipation is high for results from ongoing studies addressing critical aspects of chronic GVHD.
Keywords:
Allogeneic transplantationBIOMARKERSCONFERENCEChronic GvHDTREATMENT

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...